INOVIO PHARMACEUTICALS, INC. - INO
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 01, 2026 | Chief Medical Officer | M | D | 4,292.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 01, 2026 | Chief Medical Officer | F | D | 1,223.0 | 1.74 | 2,128.02 | 33,576.0 | View | |
| Apr 01, 2026 | Chief Medical Officer | M | A | 4,292.0 | — | — | 34,799.0 | View | |
| Mar 05, 2026 | Chief Scientific Officer | A | A | 21,560.0 | 0.0 | 0.0 | 21,560.0 | View | |
| Mar 05, 2026 | Chief Scientific Officer | A | A | 26,840.0 | 0.0 | 0.0 | 26,840.0 | View | |
| Mar 05, 2026 | Chief Medical Officer | A | A | 29,608.0 | 0.0 | 0.0 | 29,608.0 | View | |
| Mar 05, 2026 | Chief Medical Officer | A | A | 36,832.0 | 0.0 | 0.0 | 36,832.0 | View | |
| Mar 05, 2026 | Chief Executive Officer | A | A | 78,760.0 | 0.0 | 0.0 | 78,760.0 | View | |
| Mar 05, 2026 | Chief Executive Officer | A | A | 97,240.0 | 0.0 | 0.0 | 97,240.0 | View | |
| Mar 05, 2026 | CFO | A | A | 25,520.0 | 0.0 | 0.0 | 25,520.0 | View | |
| Mar 05, 2026 | CFO | A | A | 31,240.0 | 0.0 | 0.0 | 31,240.0 | View | |
| Feb 27, 2026 | CFO | M | D | 10,634.0 | 0.0 | 0.0 | 21,266.0 | View | |
| Feb 27, 2026 | CFO | M | D | 5,010.0 | 0.0 | 0.0 | 5,009.0 | View | |
| Feb 27, 2026 | CFO | F | D | 6,294.0 | 1.79 | 11,266.26 | 36,642.0 | View | |
| Feb 27, 2026 | CFO | M | A | 10,634.0 | — | — | 42,936.0 | View | |
| Feb 27, 2026 | CFO | F | D | 2,965.0 | 1.79 | 5,307.35 | 32,302.0 | View | |
| Feb 27, 2026 | CFO | M | A | 5,010.0 | — | — | 35,267.0 | View | |
| Feb 27, 2026 | Chief Executive Officer | M | D | 28,401.0 | 0.0 | 0.0 | 56,800.0 | View | |
| Feb 27, 2026 | Chief Executive Officer | M | D | 18,632.0 | 0.0 | 0.0 | 18,631.0 | View | |
| Feb 27, 2026 | Chief Executive Officer | F | D | 13,657.0 | 1.79 | 24,446.03 | 85,004.0 | View | |
| Feb 27, 2026 | Chief Executive Officer | M | A | 28,401.0 | — | — | 98,661.0 | View | |
| Feb 27, 2026 | Chief Executive Officer | F | D | 8,057.0 | 1.79 | 14,422.03 | 70,260.0 | View | |
| Feb 27, 2026 | Chief Executive Officer | M | A | 18,632.0 | — | — | 78,317.0 | View | |
| Feb 27, 2026 | Chief Medical Officer | M | D | 11,550.0 | 0.0 | 0.0 | 23,100.0 | View | |
| Feb 27, 2026 | Chief Medical Officer | M | D | 5,010.0 | 0.0 | 0.0 | 5,009.0 | View | |
| Feb 27, 2026 | Chief Medical Officer | F | D | 3,903.0 | 1.79 | 6,986.37 | 30,507.0 | View | |
| Feb 27, 2026 | Chief Medical Officer | M | A | 11,550.0 | — | — | 34,410.0 | View | |
| Feb 27, 2026 | Chief Medical Officer | M | A | 5,010.0 | — | — | 22,860.0 | View | |
| Feb 27, 2026 | — | M | D | 972.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 27, 2026 | — | M | A | 972.0 | — | — | 87,592.0 | View | |
| Feb 27, 2026 | Chief Scientific Officer | M | D | 7,366.0 | 0.0 | 0.0 | 14,732.0 | View | |
| Feb 27, 2026 | Chief Scientific Officer | M | D | 5,010.0 | 0.0 | 0.0 | 5,009.0 | View | |
| Feb 27, 2026 | Chief Scientific Officer | F | D | 3,034.0 | 1.79 | 5,430.86 | 39,900.0 | View | |
| Feb 27, 2026 | Chief Scientific Officer | M | A | 7,366.0 | — | — | 42,934.0 | View | |
| Feb 27, 2026 | Chief Scientific Officer | F | D | 2,064.0 | 1.79 | 3,694.56 | 35,568.0 | View | |
| Feb 27, 2026 | Chief Scientific Officer | M | A | 5,010.0 | — | — | 37,632.0 | View |